Cover Image

PAPERBACK
$43.50



View/Hide Left Panel

National Institute of Allergy and Infectious Diseases. 1985. Program for Accelerated Development of New Vaccines. Progress Report. Bethesda, Md.: National Institutes of Health.


Parrott, R.H., H.W.Kim, J.O.Arrobio, D.S.Hodes, B.R.Murphy, C.D. Brandt, E.Camargo, and R.M.Chanock. 1973. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am. J.Epidemiol. 98:289–300.


Taber, L.H., V.Knight, B.E.Gilbert, H.W.McClung, S.Z.Wilson, H.J. Norton, J.M.Thurson, W.H.Gordon, R.L.Atmar, and W.R.Schlaudt. 1983. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 72(5): 613–618.


Venkatesan, S., N.Elango, and R.M.Chanock. 1983. Construction and characterization of cDNA clones for four respiratory syncytial viral genes. Proc. Natl. Acad. Sci. 80(5):1280–1284.


Walsh, E.E., and J.Hruska. 1983. Monoclonal antibodies to respiratory syncytial virus proteins. Identification of the fusion protein. J. Virol. 47(1):171–177.

Wright, P.F., T.Shinozaki, W.Fleet, S.H.Sell, J.Thompson, and D.T. Karzon. 1976. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J.Pediatr. 88(6):931–936.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement